Samuel Gerssen
Directeur/Membre du Conseil chez InteRNA Technologies BV
Postes actifs de Samuel Gerssen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Directeur/Membre du Conseil | - | - |
Waterman 40 Holding BV
 Waterman 40 Holding BV Investment ManagersFinance Waterman 40 Holding BV (Waterman 40 Holding) is an Independent Private Equity/Venture Capital firm founded in 2015. The firm is headquartered in Maarsbergen. | Private Equity Investor | 01/01/2015 | - |
Alveron Pharma BV
 Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Samuel Gerssen
Statistiques
Internationale
| Pays-Bas | 4 |
Opérationnelle
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
Sectorielle
| Health Technology | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Waterman 40 Holding BV
Waterman 40 Holding BV Investment ManagersFinance Waterman 40 Holding BV (Waterman 40 Holding) is an Independent Private Equity/Venture Capital firm founded in 2015. The firm is headquartered in Maarsbergen. | Finance |
Alveron Pharma BV
Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019. | Health Technology |
- Bourse
- Insiders
- Samuel Gerssen
- Expérience
